6. What were the panel’s findings in EC-Tariff Preferences (DS246) on the consistency with the Enabling Clause of the special arrangements to combat drug trafficking in the EC’s GSP scheme? Discuss the arguments advanced by the European Communities, by India, and by the third participants (the Andean Community, Costa Rica, Panama, Paraguay and the United States) to challenge or support the Panel’s findings on this point. Did the Appellate Body agree with the panel? Why, or why not?